Bersacapavir is an experimental drug for the treatment of hepatitis B. It prevents hepatitis B virus (HBV) from replicating by inhibiting the formation of its capsid. It is also being studied for use in combination with JNJ-73763989, a small interfering RNA that targets HBV RNAs.
It can be synthesized beginning with N-methylpyrrole.
References